Perry Memorial Henry Clinic Clinic/Center - Rural Health Medicare: Not Enrolled in Medicare Practice Location: 327 Edward St, Henry, IL 61537 Phone: 309-364-2002 Fax: 309-364-2017 |
David A. Forbes, Dc,pc Clinic/Center - Multi-Specialty Medicare: Not Enrolled in Medicare Practice Location: 322 Edward St, Henry, IL 61537 Phone: 309-364-3398 Fax: 309-364-2059 |
Osf Healthcare - Medical Group - Henry Clinic/Center - Rural Health Medicare: Medicare Enrolled Practice Location: 327 Edward St, Henry, IL 61537 Phone: 309-364-2002 Fax: 309-655-4878 |
Perry Memorial Henry Clinic Clinic/Center - Primary Care Medicare: Not Enrolled in Medicare Practice Location: 327 Edward St, Henry, IL 61537 Phone: 815-875-4531 Fax: 815-876-2022 |
Osf Healthcare - Medical Group Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 327 Edward St, Henry, IL 61537 Phone: 309-364-2002 |
News Archive
American Imaging Management, Inc. (AIM), a leading diagnostic imaging benefit management and technology company with health plan clients representing more than 35 million consumers and an operating subsidiary of WellPoint, Inc. ( WLP), announced the release of new educational podcasts on the company's patient safety section of its Web site at www.americanimaging.net/safety.
What's the risk of different human populations to develop a disease? To find out, a team led by Université de Montréal professor Guillaume Lettre created an international consortium to study the blood of hundreds of thousands of people worldwide.
Scientists now are closer to understanding why older women become less fertile, suffer a miscarriage or have a baby with Down's syndrome. This could be ground breaking in infertility treatment in the older women in their late 30s and early 40s.
Dainippon Sumitomo Pharma America, Inc., a U.S. subsidiary of Dainippon Sumitomo Pharma Co., Ltd., today announced that the U.S. Food and Drug Administration recently accepted for review the lurasidone New Drug Application (NDA) for the treatment of patients with acute schizophrenia. The NDA was submitted to FDA on December 30, 2009 and will receive a standard review.
› Verified 2 days ago